Effects of Echinaforce® treatment on ex vivo-stimulated blood cells
Introduction
Virally transmitted respiratory tract infections are the most common diseases in Western countries. On average, adults suffer from 2 to 4 colds per year, whereas children can be affected up to 12 times annually (Fendrick, 2003).
Echinacea purpurea, also known as purple coneflower, is a medicinal plant. Echinacea extracts are currently used to prevent and treat influenza infections as well as the common cold (Blumenthal et al., 2007, Woelkart et al., 2008). A meta-analysis of Echinacea studies concluded that it is clinically beneficial (Schoop et al., 2006a, Shah et al., 2007, Linde et al., 2006), and various pharmacodynamic actions have been proposed (Gertsch et al., 2004). However, current knowledge about the mechanism of action of Echinacea is based mainly on in vitro research, and studies have reported different effects due to the use of different preparations from the same plant species (Gertsch et al., 2004, Rininger et al., 2000). In vitro studies have limited usefulness, as they do not reflect the bioavailability of phytochemical compounds, which are often investigated at non-physiological concentrations. In addition, a single dose of the test compound is commonly used in in vitro cultures, making this an inadequate model for investigating the effects of multiple dosing to simulate prophylactic intake of the compound. Ex vivo studies are better models for investigating drug actions, as they better reflect the effects of digestion, resorption and metabolism. Notably, the combined use of different plant parts may enhance synergistic activity: when investigating the effects of complex plant extracts, it is necessary to investigate the effect of the extract of the whole plant during and after administering the extract to the whole organism. To date, few studies have investigated the effects of repeated oral administration of Echinacea purpurea extracts on a series of chemokines and cytokines in humans using an ex vivo model.
Clinical investigations have reported the immunomodulatory effects of extracts of (mainly) freshly harvested Echinacea purpurea: prolonged 14-day treatment with single daily doses has an anti-inflammatory effect via regulation of TNF-α, interleukins, leucocytes and hsp70 as well as via superinduction of superoxide during some viral infections (i.e. common colds) (Randolph et al., 2003, Woelkart et al., 2006, Goel et al., 2004, Goel et al., 2005, Guitto et al., 2008, Agnew et al., 2005). Jurcic et al. (1989) observed increased phagocytosis after oral administration of an alcoholic extract of Echinacea purpurea, with peak induction of 120% after 5 days compared to placebo. Some preparations increased the number of leucocytes, neutrophils and monocytes, as well as the percentage of natural killer cells (Goel et al., 2005, Agnew et al., 2005); others induced no changes, and so the data remain inconclusive.
The trials cited above involved small cohorts and, in many cases, only single time point measurements i.e. before and after treatment with Echinacea. Some studies investigated isolated immune mediators in serum, while others employed ex vivo stimulation protocols to investigate the effects of Echinacea on immune cell response.
The aim of this study was to investigate the effects of repeated daily doses of a commercial Echinacea extract, Echinaforce®, on the production of several immune mediators in a heterogeneous group of subjects using an ex vivo stimulation model. Adapted effects were also observed in a subanalysis of subjects with a higher susceptibility to colds and exposure to stress and who were classified as either “strong” or “weak” immune producers based on their production of immune mediators. Sampling time points, nutritional and stress status and the presence of infections and adverse events were taken into account when assessing the effects of Echinaforce®.
Section snippets
Study design and patients
After study approval (Eudract number 2005-004013-15) by the appropriate ethics committees (Bute Medical School, University of St. Andrews and Fife and Forth Valley Local Research Ethics Committee, NHS Five) and by the Medicines and Healthcare Products Regulatory Agency (MHRA), healthy subjects (n = 30) were enrolled in the study after providing written informed consent. The age range of the 12 women and 18 men was 18–57 years, and each reported ≥2 colds per year. The subjects were studied once
Results
A total of 30 subjects were included in the study. The mean age was 24.1 ± 11.7 years, the mean mass was 67.7 ± 13.8 kg, the mean height was 171.4 ± 9.5 cm and the mean body mass index was 23 ± 3.7. Results from 28 subjects were used in the per protocol analysis: compliance could not be calculated in one subject, and one subject dropped out of the study due to difficulty in providing blood samples.
Evaluation of individual stress levels showed a mean PSS-10 score of 19.1 ± 7.6 in the first period (during
Discussion
Cytokines and chemokines play critical roles in the immune response and contribute to symptoms during respiratory tract illness. Local production of immune mediators like IL-1β, IL-6, IL-8 and TNF-α increases during the common cold and during influenza infections in normal and asthmatic subjects (de Kluijver et al., 2003). Modulation of these mediators and of leukocyte activity might represent an effective strategy for the prevention and treatment of respiratory tract diseases and their
Disclosure
This research has been founded by A. Vogel Bioforce AG, Switzerland.
Funding
This study was funded by Bioforce, Switzerland.
Acknowledgements
The authors thank Mr. Vincent Wong, Mr. Alisdair Gilmour and Miss Sarah Gates, medical students at St. Andrews University, for their outstanding assistance.
References (39)
- et al.
Synergistic stimulation of amnion cell prostaglandin E2 synthesis by interleukin-1, tumor necrosis factor and products from activated human granulocytes
Prostaglandins Leukot. Essent. Fatty Acids
(1991) - et al.
Synergistic immunopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts
Int. Immunopharmacol.
(2009) - et al.
Cytokine levels during symptomatic viral upper respiratory tract infection
Ann. Allergy. Asthma Immunol.
(2003) - et al.
Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways
FEBS Lett.
(2004) Problems and prospects of developing effective therapy for common cold viruses
Trends Microbiol.
(1997)- et al.
Slowing of wound healing by psychological stress
Lancet
(1995) Induction of Th1 and Th2 responses: a key role for the natural immune response?
Immunol. Today
(1992)- et al.
Echinacea in the prevention of induced rhinovirus colds: a meta-analysis
Clin. Ther.
(2006) - et al.
Evaluation of Echinacea for the prevention and treatment of the common cold: a meta-analysis
Lancet Infect. Dis.
(2007) - et al.
Echinacea intake induces an immune response through altered expression of leucocyte hsp70, increased white cell counts and improved erythrocyte antioxidant defences
J. Clin. Pharm. Ther.
(2005)
Three systematic reviews of Echinacea clinical trials suggest efficacy with cold symptoms
HerbalGram
A global measure of perceived stress
J. Health Soc. Behav.
Interleukin-1beta and interleukin-1ra levels in nasal lavages during experimental rhinovirus infection in asthmatic and non-asthmatic subjects
Clin. Exp. Allergy
Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock
Chest
Neuroendocrine regulation of cytokine production during experimental influenza viral infection: effects of restraint stress-induced elevation in endogenous corticosterone
J. Immunol.
Viral respiratory infections due to rhinoviruses: current knowledge
Am. J. Ther.
Stress depresses interferon production by leukocytes concomitant with a decrease in NK cell activity
Behav. Neurosci.
Pharmacokinetics and immunomodulatory effects of phytotherapeutic lozenges (bonbons) with Echinacea purpurea extract
Phytotherapy
Efficacy of a standardized Echinacea preparation (Echinilin™) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial
J. Clin. Pharm. Ther.
Cited by (26)
Response to Dr. DF Naude
2022, ExploreEffects of an oral hydro-ethanolic purple coneflower extract on performance, clinical health and immune parameters in calves
2021, Research in Veterinary ScienceCitation Excerpt :This effect might be due to immune stimulating effects of EP as already reported previously (Ayrle et al., 2016a; Barnes et al., 2005; Barrett, 2003). On the contrary, cytokines and other mediators involved in the development of fever (IL-1β and TNFα) have been reported to be downregulated after EP treatment in mice and humans (Ritchie et al., 2011; Zhai et al., 2007). The mechanism behind the increased body temperature remains unclear but future studies researching effects of EP in mammals should pay more attention to this important clinical parameter.
Daily intake of a homeopathic agent by dogs modulates white cell defenses and reduces bacterial counts in feces
2021, Microbial PathogenesisCitation Excerpt :The use of immunostimulants can also be considered in the adjunctive use of vaccines or as immunotherapies with no specific antigenic effect; this occurs in phytochemicals even in extremely low doses [10,11], as is the case with homeopaths. An impaired immune response in individuals subjected to stress factors and pathogens leads to disease or inadequate protective responses [12]. Therefore, this work's objective was to evaluate the effects of a homeopathic on blood cell counts, serum protein levels, and fecal bacterial counts in dogs.
The effect of Echinacea spp. on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review
2020, Advances in Integrative MedicineCitation Excerpt :Of these, five included healthy participants who consumed oral doses of Echinacea before blood levels of cytokines were measured [21–25]. Three studies included participants with respiratory tract infections [4,5,8] and four included healthy participants whose ex vivo blood samples were stimulated and immune response observed [26,27,28,29]. The studies assessed cytokines including TNFα (n = 9), IL-1B, IL-2, IL-3 IL-6, IL-8, IL-10, IL-12 and Interferon (IFN)α2.